Patents Assigned to KAPA BIOSYSTEMS
  • Patent number: 9023633
    Abstract: The present invention provides, among other things, chimeric DNA polymerases containing heterologous domains having sequences derived from at least two DNA polymerases that have at least one distinct functional characteristics (e.g., elongation rate, processivity, error rate or fidelity, salt tolerance or resistance) and methods of making and using the same. In some embodiments, the present invention can combine desired functional characteristics (e.g., high processivity; high elongation rate; thermostability; resistance to salt, PCR additives (e.g., PCR enhancers) and other impurities; and high fidelity) of different DNA polymerases in a chimeric polymerase.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: May 5, 2015
    Assignee: Kapa Biosystems
    Inventors: Bjarne Faurholm, Paul McEwan, William Bourn, Gavin Rush
  • Patent number: 8481685
    Abstract: The present invention provides, among other things, modified DNA polymerases containing amino acid alterations based on mutations identified in directed evolution experiments designed to select enzymes that are better suited for applications in recombinant DNA technologies.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: July 9, 2013
    Assignee: Kapa Biosystems
    Inventors: William Bourn, Bjarne Faurholm, John Foskett
  • Publication number: 20120115188
    Abstract: The present invention provides, among other things, chimeric DNA polymerases containing heterologous domains having sequences derived from at least two DNA polymerases that have at least one distinct functional characteristics (e.g., elongation rate, processivity, error rate or fidelity, salt tolerance or resistance) and methods of making and using the same. In some embodiments, the present invention can combine desired functional characteristics (e.g., high processivity; high elongation rate; thermostability; resistance to salt, PCR additives (e.g., PCR enhancers) and other impurities; and high fidelity) of different DNA polymerases in a chimeric polymerase.
    Type: Application
    Filed: November 3, 2009
    Publication date: May 10, 2012
    Applicant: KAPA BIOSYSTEMS
    Inventors: Bjarne Faurholm, Paul McEwan, William Bourn, Gavin Rush
  • Publication number: 20110269211
    Abstract: The present invention provides, among other things, modified DNA polymerases containing amino acid alterations based on mutations identified in directed evolution experiments designed to select enzymes that are better suited for applications in recombinant DNA technologies.
    Type: Application
    Filed: November 3, 2009
    Publication date: November 3, 2011
    Applicant: KAPA BIOSYSTEMS
    Inventors: William Bourn, Bjarne Faurholm, John Foskett